Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/15/2010EP1631294B1 A method of treating an anxiety disorder
09/15/2010EP1611144B1 Derivatives of 2-(8,9-dioxo-2,6-diazabicyclo(5.2.0)non-1(7)-en-2-yl)alkyl phosphonic acid and their use as n-methyl-d-aspartate (nmda) recetor antagonists
09/15/2010EP1611131B1 Pyrazolopyridine derivates
09/15/2010EP1578748B1 Tetrahydro-4h-pyrido[1,2-a]pyrimidines and related compounds useful as hiv integrase inhibitors
09/15/2010EP1576179B1 Methods and compositions for inducing apoptosis in cancer cells
09/15/2010EP1569908B1 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors
09/15/2010EP1536839B1 Combination therapy comprising omega-interferon for treating infection with hepatitis c virus or yellow fever virus
09/15/2010EP1536837B1 Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
09/15/2010EP1519713B1 Systems for releasing active ingredients, based on biodegradable or biocompatible polymers with a shape memory effect
09/15/2010EP1501819B1 Estrogen receptor modulators
09/15/2010EP1467744B1 Aqueous compositions containing metronidazole
09/15/2010EP1354196B1 Diagnostics, drug screening and treatment for cancer
09/15/2010EP1351681B1 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
09/15/2010EP1303596B1 Morpholino antisense oligomers as enzyme inhibitors for improving pharmacokinetics of a drug
09/15/2010CN201578612U Combined capsule filled with angiotonin II acceptor antagonist solid preparation and hydrochlorothiazidum solid preparation
09/15/2010CN201578611U Combined capsule filled with hydrochlorothiazidum solid preparation and benazepril solid preparation
09/15/2010CN201578610U Combined capsule filled with pamabrom solid preparation and acetaminopher solid preparation
09/15/2010CN1969918B Oral fat emulsion
09/15/2010CN1951502B Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
09/15/2010CN1923784B 4,5-ringopening diterpene quinine analogue and use thereof
09/15/2010CN1911237B Beta - l-2'-deoxy-nucleosides for the treatment of hepatitis b
09/15/2010CN1879637B A medicine for treating cardiovascular and cerebrovascular disease
09/15/2010CN1816330B Antiseptic compositions, methods and systems
09/15/2010CN101835894A EBI3, DLX5, NPTXl and CDKN3 for target genes of lung cancer therapy and diagnosis
09/15/2010CN101835893A Cancer-related genes, CDCA5, EPHA7, STK31 and WDHD1
09/15/2010CN101835806A An exopolysaccharide
09/15/2010CN101835787A C2-C5-alkyl-imidazole-bisphosphonates
09/15/2010CN101835784A Spiro [piperidine-4, 4'-thieno [3, 2-C] pyran] derivatives and related compounds as inhibitors of the sigma receptor for the treatment of psychosis
09/15/2010CN101835783A Process for producing carnosol from carnosic acid
09/15/2010CN101835782A Process for producing carnosol from carnosic acid using hydrogen peroxide or peracids
09/15/2010CN101835780A Imidazo [1,2-alpha] pyrazine compounds for treatment of viral infections such as hepatitis
09/15/2010CN101835779A Purine derivatives useful as PI3 kinase inhibitors
09/15/2010CN101835778A Hdac inhibitors
09/15/2010CN101835777A Carbacephem beta-lactam antibiotics
09/15/2010CN101835776A Fused imidazoles for cancer treatment
09/15/2010CN101835775A 4,4-disubstituted piperidines
09/15/2010CN101835774A Co-crystals and pharmaceutical compositions comprising the same
09/15/2010CN101835773A Novel imidazole derivatives
09/15/2010CN101835772A Novel imidazole derivatives
09/15/2010CN101835771A Aminobenzyl-substituted cyclic sulfones useful as bace inhibitors
09/15/2010CN101835770A Condensed compounds with activity at estrogen receptors
09/15/2010CN101835766A New compounds as adenosine a1 receptor antagonists
09/15/2010CN101835765A Alkylsulfonyl-substituted thiazolide compounds
09/15/2010CN101835764A Azolecarboxamide compound or salt thereof
09/15/2010CN101835763A Oxadiazolidinedione compound
09/15/2010CN101835762A 2-aminooxazole derivatives as TRPV1 antagonists useful for treating pain
09/15/2010CN101835761A Substituted piperazines
09/15/2010CN101835760A Arylindenopyrimidines and their use as adenosine A2a receptor antagonists
09/15/2010CN101835759A Arylindenopyrimidines and their use as adenosine A2a receptor antagonists
09/15/2010CN101835757A Diacylglycerol acyltransferase inhibitors
09/15/2010CN101835756A 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators
09/15/2010CN101835755A Novel kinase inhibitors
09/15/2010CN101835751A Cyclohexeneamide derivatives and their use as TRPV1 antagonist
09/15/2010CN101835748A Amino arylsulfonamide compounds and their use as 5-HT6 ligands field of invention
09/15/2010CN101835747A Benzimidazole derivative
09/15/2010CN101835741A Bis-aromatic compounds useful in the treatment of inflammation
09/15/2010CN101835737A Spiro-ring compound and use thereof for medical purposes
09/15/2010CN101835728A Compounds for use in imaging, diagnosing, and/or treatment of diseases of the central nervous system or of tumors
09/15/2010CN101835503A Compositions and kits for treating influenza
09/15/2010CN101835501A Composition for treatment of joint disease
09/15/2010CN101835491A Agent for promoting corneal endothelial cell adhesion
09/15/2010CN101835486A Pharmaceutical composition and related methods
09/15/2010CN101835477A Composition for reducing the level of glucose, malondialdehyde-modified LDL, homocysteine and/or c-reactive protein in blood
09/15/2010CN101835476A Impaired wound healing compositions and treatments
09/15/2010CN101835475A Azithromycin for treatment of skin disorders
09/15/2010CN101835474A Idarubicin for the treatment of lymphoma in a dog
09/15/2010CN101835473A Novel ophthalmic compositions
09/15/2010CN101835472A Methods of administering N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea to treat proliferative disease
09/15/2010CN101835471A Amine derivative having NPY Y5 receptor antagonist activity and use thereof
09/15/2010CN101835470A Pharmaceutical compositions comprising semicarbazones and thiosemicar-bazones and method for treating inflammatory, painful and febrile conditions and preventing signs and symptoms
09/15/2010CN101835469A 1-amino-alkylcyclohexane derivatives for the treatment and prevention of hearing loss
09/15/2010CN101835467A Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
09/15/2010CN101835466A Clonidine formulations in a biodegradable polymer carrier
09/15/2010CN101835465A Sulindac formulations in a biodegradable material
09/15/2010CN101835464A Anti-malarial pharmaceutical composition
09/15/2010CN101835390A Reduction of oxidative stress damage during or after exercise
09/15/2010CN101835375A Vegfr inhibitors containing a zinc binding moiety
09/15/2010CN101831478A Preparation method of 5'-acylate uridine and application in preparing medicaments for treating heart diseases and liver diseases
09/15/2010CN101831071A Degradable poly (lactic acid-glutamic acid) crosslinking microgel, preparation and application thereof
09/15/2010CN101831005A PH sensitive type chitosan derivant and application thereof in pharmaceutics
09/15/2010CN101831004A Hyaluronic acid strontium salt compounds, preparation method thereof and application in medicine
09/15/2010CN101830964A Triterpenoid compounds with anti-inflammatory activities
09/15/2010CN101830963A Bufogenin compound and application thereof in preparing anti-tumor medicaments
09/15/2010CN101830961A Ursolic acid ester derivatives, preparation method thereof and application thereof
09/15/2010CN101830958A 20(R)-25-ethyoxyl-dammarane-3beta,12beta,20-triol and preparation method thereof
09/15/2010CN101830949A Azithromycin derivative as well as intermediate, preparation method and application thereof
09/15/2010CN101830945A Arteannuin derivative and use thereof
09/15/2010CN101830935A Solanum cathayanum alkaloid extract and preparation method and application thereof
09/15/2010CN101830916A Cefbuperazone sodium hydrate, preparation method thereof and application thereof
09/15/2010CN101830915A Cefodizime sodium hydrate, preparation method thereof and application thereof
09/15/2010CN101830911A Thienopyridine derivatives, preparation method and application thereof
09/15/2010CN101830903A Aildenafil citrate crystal form O, preparation method and application thereof
09/15/2010CN101830899A Heterocyclic carbamate derivatives, their manufacture and use as pharmaceutical agents
09/15/2010CN101830897A Novel isoquinoline alkaloid derivatives and preparation method and application thereof
09/15/2010CN101830896A Organic acid salt of optical isomer of penehyclidine
09/15/2010CN101830895A Aztreonam anhydrous crystal compound and preparation method thereof
09/15/2010CN101830894A Benzo[d]oxazole compounds and preparation method thereof
09/15/2010CN101830889A 嘧啶衍生物 Pyrimidine derivatives
09/15/2010CN101830884A Macrolide as well as preparation method and antibacterial application thereof
09/15/2010CN101830879A 5-phenoxybutyldimethylapiolin, preparation method and application
1 ... 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 ... 7860